Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 287,600 | 183,100 | 146,700 | 218,700 | 202,400 |
| Marketable Securities | 1,900 | 5,200 | 3,700 | 8,100 | 12,100 |
| Receivables | 280,500 | 274,500 | 255,800 | 204,700 | 213,600 |
| Inventories | 168,700 | 160,900 | 146,100 | 151,800 | 143,800 |
| Income taxes - deferred | 44,700 | 38,300 | 35,600 | 42,400 | 28,000 |
| Other current assets | 53,100 | 38,800 | 25,900 | 35,500 | 38,600 |
| TOTAL | $877,200 | $745,600 | $649,000 | $691,900 | $676,300 |
| Non-Current Assets | |||||
| PPE Net | 240,700 | 239,100 | 229,800 | 230,100 | 224,000 |
| Investments And Advances | 24,800 | 20,300 | 16,600 | 14,700 | 20,300 |
| Intangibles | 406,200 | 407,000 | 408,300 | 412,600 | 423,600 |
| Other Non-Current Assets | 53,200 | 53,100 | 55,200 | 50,900 | 37,000 |
| TOTAL | $724,900 | $719,500 | $709,900 | $708,300 | $704,900 |
| Total Assets | $1,602,100 | $1,465,100 | $1,358,900 | $1,400,200 | $1,381,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 296,300 | 245,100 | 200,200 | 65,600 | 229,900 |
| Accrued Expenses | N/A | N/A | N/A | 186,700 | N/A |
| TOTAL | $296,300 | $245,100 | $200,200 | $258,500 | $229,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 102,300 | 113,900 | 123,000 | 175,500 | 202,800 |
| Other Non-Current Liabilities | 113,100 | 103,000 | 92,400 | 87,400 | 74,000 |
| TOTAL | $215,400 | $216,900 | $215,400 | $262,900 | $276,800 |
| Total Liabilities | $511,700 | $462,000 | $415,600 | $521,400 | $506,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 678,829 | 677,027 | 672,055 | 670,503 | 667,954 |
| Common Shares | 75,400 | 75,100 | 74,300 | 73,700 | 73,300 |
| Retained earnings | 858,400 | 784,900 | 737,400 | 676,900 | 639,400 |
| Other shareholders' equity | -6,900 | -24,000 | -33,400 | -35,200 | 5,200 |
| TOTAL | $1,090,400 | $1,003,100 | $943,300 | $878,800 | $874,500 |
| Total Liabilities And Equity | $1,602,100 | $1,465,100 | $1,358,900 | $1,400,200 | $1,381,200 |